Latest Breaking News On - Infusion system - Page 4 : comparemela.com

TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting

– New safety and feasibility data from Phase 1/1b PERIO-03 trial for locally advanced pancreatic cancer supports further development of the novel TriSalus Infusion System for therapeutic delivery.

United statesTrisalu trinavStevenc katzCenters for medicare medicaid servicesUniversity of texas md anderson cancer centerSociety of interventional radiology annual scientific meetingCurrent medical researchTrisalus life sciencesSociety of interventional radiologyInterventional radiology annual scientificPressure enabled drug deliveryTrisalus infusion systemHypovascular solidCancer centerInterventional radiologyMedicaid services

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionTrisalus life sciencesSee the company quarterly report on formSalus life sciencesUnaudited fourth quarterFull yearInfusion systemPressure enabled drug deliveryPancreatic retrograde venous infusion systemPressure enabled regional immuno oncologyPrivate securities litigation reform actQuarterly reportInvestor inquiriesTrisalus life

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

KORU Medical Systems, Inc. , a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion.

United statesLinda tharbyEuropean unionSystems incInfusion systemFreedom systemFreedom infusion systemSyringe infusion driversPrecision flow rateH flo subcutaneous safety needlePrivate securities litigation reform actAnnual reportQuarterly report

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors

DENVER (BUSINESS WIRE) Feb 29, 2024

United statesMary szelaTrinav smartvalveStevenc katzCenters for medicareCurrent medical researchTrisalus life sciencesSalus life sciencesChief executive officerHealthcare common procedure coding systemChief medical officerTrinav infusionPressure enabled drug deliveryTranscatheter arterial chemoembolizationTranscatheter arterial radioembolizationInfusion system

Becton, Dickinson and Company (NYSE:BDX) Q1 2024 Earnings Call Transcript

Becton, Dickinson and Company (NYSE:BDX) Q1 2024 Earnings Call Transcript February 1, 2024 Becton, Dickinson and Company beats earnings expectations. Reported EPS is $2.68, expectations were $2.39. Becton, Dickinson and Company isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome […]

United statesChristopher deloreficeBd life sciencesGrowth in medication delivery solutionsSoftware engineersCatheter solutionsLatin americaInfusion systemPharmacy automationPharmaceutical systemsMedication delivery solutionsVascular access managementClinical reagentsRotarex atherectomy systemStress high paying jobs in the worldBest software